The heterotypic adhesion between cancer cells and endothelia also promotes signaling by CDH2 binding molecules such as p120 and β-Catenin, leading to the dissolution of VE-Cadherin-mediated endothelial junction and facilitating the TEM of the cancer cells (107–109). This evidence concerns the gene CDH5 and cancer.